Incorporation of two doctors to the R&D&i within the "Torres Quevedo" program 2020 call


No votes yet
 
Related
Today, Laboratorios Farmacéuticos Rovi, S.A. (“ROVI” or the “Company”) has announced that the European Commission has authorised the...
3 min
15/02/2022
  Madrid - January 28, 2022 Last May, ROVI signed a financing agreement with the Centre for Industrial Technological Development...
1 min
28/01/2022
ROVI recibe la opinión positiva del CHMP para Okedi® como tratamiento de la esquizofrenia
Laboratorios Farmacéuticos Rovi, a pan-European pharmaceutical company specializing and engaging in the research, development, contract...
4 min
17/12/2021